ArticleSurgery today2026
Robot-assisted surgery for colorectal cancer using the Hugo™ RAS system: an observational study with the initial 118 cases and a literature review.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeRobot-assisted surgery has been widely adopted for treating colorectal cancer (CRC). The Hugo™ robotic-assisted surgery (Hugo) system is a novel modular robotic platform; however, clinical data regarding its use for CRC remain limited. This study aimed to evaluate the perioperative and short-term outcomes of surgery for CRC using Hugo.
methodsIn this single-center, retrospective observational study, consecutive patients with CRC who underwent Hugo-assisted surgery were included. The clinicopathological characteristics and short-term outcomes were analyzed. All procedures were performed by or under the supervision of a surgeon with substantial experience in robot-assisted colorectal surgery.
resultsA total of 118 patients were included (57 with colon cancer and 61 with rectal cancer). The median operative times were 281 and 328 min for colon and rectal cancers, respectively. There were Clavien-Dindo Grade II complications in three patients with colon cancer and six with rectal cancer, and Grade III complications in two patients in the colon and one in the rectal cancer group. There were no intraoperative complications or conversions to open surgery.
conclusionsHugo-assisted surgery for CRC is feasible and safe. As the largest single-center series reported to date, this study provides important clinical evidence supporting the applicability of Hugo.
Indexed as
Identifiers
42627502What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.